Usefulness of Early Treatment with Efgartigimod in Patients with Generalized Myasthenia Gravis Complicated by Cardiovascular Disease: A Case Report
Efgartigimod may represent a feasible alternative to conventional FT for the management of gMG, particularly in patients with significant cardiovascular comorbidities.
Authors
- Kazushi Deguchi (ORCID: https://orcid.org/0000-0001-7576-8426)
- Rie Kawakita
Institutions
- Kagawa University (JP)
- Takamatsu University (JP)
Publication Details
- Journal
- Case Reports in Neurology
- Published
- 2026-02-09
- DOI
- https://doi.org/10.1159/000550908
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00